Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
- 1 May 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (18), 7516-7521
- https://doi.org/10.1073/pnas.0610299104
Abstract
Multiple myeloma (MM) is an invariably fatal form of cancer characterized by clonal proliferation of malignant plasma cells in the bone marrow. The canonical Wnt signaling pathway is activated in MM cells through constitutively active β-catenin, a messenger molecule relevant to growth, survival, and migration of MM cells. The identification of a number of small molecular compounds, such as PKF115–584, which disrupt the interaction of the transcriptionally active β-catenin/TCF protein complex, provides valuable new therapeutic tools to target an alternative pathway in MM independent of the proteasome. Here we evaluated the transcriptional, proteomic, signaling changes, and biological sequelae associated with the inhibition of Wnt signaling in MM by PKF115–584. The compound blocks expression of Wnt target genes and induces cytotoxicity in both patient MM cells and MM cell lines without a significant effect in normal plasma cells. In xenograft models of human MM, PKF115–584 inhibits tumor growth and prolongs survival. Taken together, these data demonstrate the efficacy of disrupting the β-catenin/TCF transcriptional complex to exploit tumor dependence on Wnt signaling as a therapeutic approach in the treatment of MM.Keywords
This publication has 41 references indexed in Scilit:
- Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivoBlood, 2006
- Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cellsBritish Journal of Haematology, 2006
- Regulation of bone mass by Wnt signalingJCI Insight, 2006
- High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsCancer Cell, 2006
- Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulationMolecular Therapy, 2005
- Wnt signalling in stem cells and cancerNature, 2005
- WNT signalling and haematopoiesis: a WNT–WNT situationNature Reviews Immunology, 2005
- Endothelial cells in the bone marrow of patients with multiple myelomaBlood, 2003
- Wnt signaling in B-cell neoplasiaOncogene, 2003
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996